Regents
-
May 19, 2016
Regents Roundup — May 2016
Other agenda items approved by the Board of Regents at its meeting Thursday.
-
April 21, 2016
Regents Roundup — April 2016
Other items approved by the Board of Regents at its meeting Thursday.
-
April 21, 2016
Executive vice dean for academic affairs named at Medical School
Dr. Carol R. Bradford, an internationally recognized head and neck cancer researcher and faculty leader with a track record in promoting diversity, is the Medical School’s executive vice dean for academic affairs.
-
April 21, 2016
Gift helps students realize vision for multicultural center
The university has received a $3 million gift from Regent Mark Bernstein and his wife, Rachel Bendit, to help fund a new building that will house the William Monroe Trotter Multicultural Center.
-
April 21, 2016
Thomas Finholt named dean of the School of Information
Thomas A. Finholt, a member of the U-M faculty since 1991, has been appointed dean of the School of Information. His appointment takes effect May 1 and runs through June 30, 2021.
-
April 21, 2016
Lynn Videka named dean of the School of Social Work
Lynn Videka, dean and professor in the Silver School of Social Work at New York University, will serve as the next dean of the U-M School of Social Work.
-
April 21, 2016
New fund to accelerate engineering, medical research products
U-M has launched the Monroe-Brown Seed Fund to advance the process of transitioning commercially viable engineering and medical research projects to market.
-
April 21, 2016
Rowley appointed AVP for research — social sciences and humanities
Stephanie J. Rowley has been appointed associate vice president for research — social sciences and humanities in the U-M Office of Research.
-
March 17, 2016
Bursley Hall dining center scheduled for renovation
The Bursley Hall dining center, the only residential dining facility on North Campus, will undergo a $4.3 million renovation this summer.
-
March 17, 2016
Shayman named 2016 Distinguished University Innovator
Dr. James A. Shayman, developer of a new class of drugs for treating a group of rare but devastating congenital disorders, has been named U-M’s Distinguished University Innovator for 2016.
